Shanghai Allist Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005XJ7
CNY
96.27
0.27 (0.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,509.27
1,991.58
785.90
527.30
-1.08
-1.19
3.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,509.27
1,991.58
785.90
527.30
-1.08
-1.19
3.00
Raw Material Cost
178.77
114.71
54.41
30.03
12.66
9.81
6.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.13
0.21
0.36
0.64
1.19
7.82
6.06
Selling and Distribution Expenses
1,560.75
1,032.88
511.09
353.26
177.87
228.10
14.72
Other Expenses
29.63
29.44
18.31
21.13
16.90
14.88
8.52
Total Expenditure (Excl Depreciation)
2,035.95
1,442.24
748.94
595.18
360.74
394.55
112.52
Operating Profit (PBDIT) excl Other Income
1473.3000000000002
549.3
37
-67.9
-361.8
-395.7
-109.5
Other Income
114.60
84.05
57.82
37.25
44.19
1.65
18.20
Operating Profit (PBDIT)
1,629.56
673.94
122.74
-2.93
-305.11
-384.55
-86.28
Interest
0.13
0.21
0.36
0.64
1.19
7.82
6.06
Exceptional Items
28.89
22.67
30.65
47.56
8.28
4.40
0.00
Gross Profit (PBDT)
3,330.49
1,876.87
731.49
497.27
-13.74
-11.00
-3.55
Depreciation
39.80
40.19
27.02
25.71
12.50
9.54
5.05
Profit Before Tax
1,618.52
656.22
126.00
18.27
-310.52
-397.50
-97.39
Tax
188.67
12.05
-4.52
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,429.85
644.17
130.52
18.27
-310.52
-397.50
-97.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,429.85
644.17
130.52
18.27
-310.52
-397.50
-97.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,429.85
644.17
130.52
18.27
-310.52
-397.50
-97.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,282.81
3,982.28
3,187.06
2,973.26
2,878.05
1,184.39
71.04
Earnings per share (EPS)
3.18
1.43
0.29
0.04
-0.69
-0.88
-0.22
Diluted Earnings per share
3.18
1.43
0.29
0.04
-0.69
-0.88
-0.22
Operating Profit Margin (Excl OI)
42.04%
27.6%
4.82%
-12.5%
0.0%
0.0%
-3655.1%
Gross Profit Margin
47.26%
34.97%
19.47%
8.34%
27586.3%
32519.47%
-3081.82%
PAT Margin
40.74%
32.34%
16.61%
3.47%
0.0%
0.0%
-3250.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 76.21% vs 153.42% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 121.95% vs 393.64% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 156.82% vs 808.94% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -50.00% vs -50.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Shanghai Allist Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,509.27
0
3,509.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,509.27
0
3,509.27
Raw Material Cost
178.77
0
178.77
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.13
0
0.13
Selling and Distribution Expenses
1,560.75
0
1,560.75
Other Expenses
29.63
0.00
29.63
Total Expenditure (Excl Depreciation)
2,035.95
0
2,035.95
Operating Profit (PBDIT) excl Other Income
1,473.32
0.00
1,473.32
Other Income
114.60
0
114.60
Operating Profit (PBDIT)
1,629.56
0
1,629.56
Interest
0.13
0
0.13
Exceptional Items
28.89
0
28.89
Gross Profit (PBDT)
3,330.49
0
3,330.49
Depreciation
39.80
0
39.80
Profit Before Tax
1,618.52
0
1,618.52
Tax
188.67
0
188.67
Provisions and contingencies
0
0
0.00
Profit After Tax
1,429.85
0
1,429.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,429.85
0
1,429.85
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,429.85
0
1,429.85
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,282.81
0
5,282.81
Earnings per share (EPS)
3.18
0
3.18
Diluted Earnings per share
3.18
0
3.18
Operating Profit Margin (Excl OI)
42.04%
0%
0.00
42.04%
Gross Profit Margin
47.26%
0%
0.00
47.26%
PAT Margin
40.74%
0%
0.00
40.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 350.93 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 76.21% vs 153.42% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 142.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 121.95% vs 393.64% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 151.50 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 156.82% vs 808.94% in Dec 2023

Annual - Interest
Interest 0.01 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -50.00% vs -50.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 42.04%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023